viewpoint: china has the upper hand in cancer cell therapy.
.
"as soon as she saw him," said tamara nunley, r.n., "you could see her perk up.".
the news highlighted another factor in the chinese threat: regardless of the different regulatory framework, many researchers think the data they report is valid...